Evidence map›Paper›PMID 16040251›Full record

ArticleJournal of photochemistry and photobiology. B, Biology2005

Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria.

Tatiana N Demidova, Faten Gad, Touqir Zahra, Kevin P Francis, Michael R Hamblin

Abstract read
In one paragraph

Article in Journal of photochemistry and photobiology. B, Biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. 2D MoSNano convergence · 2026
    Article
  3. Article
  4. The Role of Porphyrinoid Photosensitizers for Skin Wound Healing.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Tetracyclines: light-activated antibiotics?Future medicinal chemistry · 2019
    Review
  8. Article
  9. Review
  10. Article
  11. A Multimodal Imaging Approach EnablesAntimicrobial agents and chemotherapy · 2018
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Photodynamic therapy of oral Candida infection in a mouse model.Journal of photochemistry and photobiology. B, Biology · 2016
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tatiana N DemidovaWellman Center for Photomedicine, Massachusetts General Hospital, BAR414, 40 Blossom Street, Boston, MA, USA.
Faten Gad
Touqir Zahra
Kevin P Francis
Michael R Hamblin
Massachusetts General Hospital · USHarvard University · USTufts University · US

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
NIAID NIH HHS AI 050875NIAID NIH HHS R01 AI050875
6 · The paper itself

Abstract

The increasing occurrence of multi-antibiotic resistant microbes has led to the search for alternative methods of killing pathogens and treating infections. Photodynamic therapy (PDT) uses the combination of non-toxic dyes and harmless visible light to produce reactive oxygen species that can kill mammalian and microbial cells. Although the photodynamic inactivation of bacteria has been known for over a hundred years, its use to treat infections has not been much developed. This may be partly due to the difficulty of monitoring the effectiveness of PDT in animal models of infection. In order to facilitate this monitoring process, we have developed a procedure that uses bioluminescent genetically engineered bacteria and a light sensitive imaging system to allow real-time visualization of infections. When these bacteria are treated with PDT in vitro, the loss of luminescence parallels the loss of colony-forming ability. We have developed several models of infections in wounds and soft-tissue abscesses in mice that can be followed by bioluminescence imaging. The size and intensity of the infection can be sequentially monitored in a non-invasive fashion in individual mice in real-time. When photosensitizers are introduced into the infected tissue followed by illumination with red light, a light-dose dependent loss of luminescence is seen. If the bacterium is invasive, the loss of luminescence correlates with increased survival of the mice, whilst animals in control groups die of sepsis within five days. Healing of the PDT treated wounds is not impaired and may actually be improved. This approach can allow many animal models of localized infections to be accurately monitored for efficacy of treatment by PDT.

Indexed as

PhotochemotherapyAnimalsChlorophyllidesEscherichia coli InfectionsLuciferasesLuminescent MeasurementsMicePolylysinePorphyrinsPseudomonas InfectionsSoft Tissue InfectionsStaphylococcal InfectionsTransformation, GeneticWound InfectionChlorophyllidesLuciferasesphytochlorinPolylysinePorphyrins

Identifiers

PMID16040251
PMCPMC3071690
OpenAlexW2042105116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.